A STUDY OF PHARMACOKINETIC INTERACTION BETWEEN MANGIFERIN AND ATORVASTATIN IN HYPERLIPIDEMIC RATS
DOI:
https://doi.org/10.22159/ijap.2025v17i1.52248Keywords:
Atorvastatin, Mangiferin, Hyperlipidemia, PharmacokineticsAbstract
Objective: The main aim of this study is to determine the effect of Mangiferin on the pharmacokinetics of Atorvastatin in hyperlipidemic rats.
Methods: The plasma concentration of Atorvastatin (ATR) to the time profile was calculated using High Performance Liquid Chromatography (HPLC). The experiment was carried out in normal and High Fat Diet (HFD) induced hyperlipidemic rats in single and multiple-dose treated rats for pharmacokinetic study. HFD was administered to the rats for 8 w to induce hyperlipidemia. Each group contains six animals, Group I received ATR alone (20 mg/kg), Group II received Mangiferin (MGF) (40 mg/kg) followed by ATR for Single-Dose Interaction(SDI), Group III received MGF for 7 days, followed by ATR on 8th d for Multiple Dose Interaction (MDI). Blood samples were collected and estimated for pharmacokinetic parameters such as the Area under Curve (AUC), Maximum Plasma Concentration (Cmax), Time to achieve Cmax (Tmax), Biological Half-Life (t1/2), mean Residence Time (MRT) and Volume of distribution (Vd), Clearance (CL) and Elimination Rate Constant (Ke).
Results: In normal and disease-induced rats of SDI and MDI studies it has shown increased plasma concentration of ATR in the presence of MGF. MGF significantly increased the following pharmacokinetic parameters: Cmax (83.56±5.94 ng/ml) in SDI, (100.28±6.37 ng/ml) in MDI, AUC (265.25±14.73ng. h/ml) in SDI, (299.04±14.11ng. h/ml) in MDI. t1/2, Vd, and MRT were also enhanced in both studies. However, CL and Ke were reduced significantly.
Conclusion: This study revealed that MGF altered the ATR pharmacokinetics. This could be due to MGF Cytochrome P450 (CYP3A) enzyme inhibition.
Downloads
References
Kelly RB. Diet and exercise in the management of hyperlipidemia. Am Fam Physician. 2010;81(9):1097-102. PMID 20433126.
Laka K, Makgoo L, Mbita Z. Cholesterol lowering phytochemicals: targeting the mevalonate pathway for anticancer interventions. Front Genet. 2022;13:841639. doi: 10.3389/fgene.2022.841639, PMID 35391801.
Mc Iver LA, Siddique MS. Atorvastatin. In: Treasure Island (FL): StatPearls Publishing; 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430779. [Last accessed on 22 Nov 2024].
Walia V, Chaudhary SK, Kumar Sethiya N. Therapeutic potential of mangiferin in the treatment of various neuropsychiatric and neurodegenerative disorders. Neurochem Int. 2021;143:104939. doi: 10.1016/J.NEUINT.2020.104939, PMID 33346032.
Imran M, Arshad MS, Butt MS, Kwon JH, Arshad MU, Sultan MT. Mangiferin: a natural miracle bioactive compound against lifestyle related disorders. Lipids Health Dis. 2017;16(1):84. doi: 10.1186/s12944-017-0449-y, PMID 28464819.
Mujawdiya PK, and Kapur S. Mangiferin: a potential natural molecule for management of metabolic syndrome. Int J Pharm Pharm Sci. 2015;7(13):9-13.
Ayuni Lubakisar YQ, Fauziah F, Bellatasie R. Immunomodulator activity of mangiferin from mango (Mangifera indica L.) in cancer: a systematic review. Int J Pharm Pharm Sci. 2021;13(10):7-11. doi: 10.22159/ijpps.2021v13i10.42095.
Timsina B, Nadumane VK. Mango seeds: a potential source for the isolation of bioactive compounds with anticancer activity. Int J Pharm Pharm Sci. 2015;7(13):89-95.
Wadhwa K, Rana AC. A review on liquid chromatographic methods for the bioanalysis of atorvastatin. Futur J Pharm Sci. 2021;7(1):1-19. doi: 10.1186/s43094-020-00146-7.
Entidhar J, Abdul Rasool AA, Badwan AA, Nawzat D, Jbour AL, Qinna NA. Development and validation of a sensitive and accurate method for determination of atorvastatin and rosuvastatin in rat plasma by reversed-phase high-performance liquid chromatography with UV detection. Int J Pharm Pharm Sci. 2013;5(2):211-9.
Raul SK, Aravelli RB, Jhansi D. RP-HPLC method development and validation for the simultaneous estimation of atorvastatin and ezetimibe in the pharmaceutical dosage form. Asian J Pharm Clin Res. 2015;8(2):178-81.
Sampathkumar MT, Kasetti RB, Nabi SA, Sudarshan PR, Swapna S, Apparao C. Antihyperlipidemic and antiatherogenic activities of terminalia pallida Linn. fruits in high-fat diet induced hyperlipidemic rats. J Pharm Bioallied Sci. 2011;3(3):449-52. doi: 10.4103/0975-7406.84464, PMID 21966168.
Zeng H, Liu Z. Atorvastatin induces hepatotoxicity in diabetic rats via oxidative stress inflammation and anti-apoptotic pathway. Med Sci Monit. 2019;25:6165-73. doi: 10.12659/MSM.915790, PMID 31420530.
Sellamuthu PS, Arulselvan P, Muniappan BP, Fakurazi S, Kandasamy M. Mangiferin from salacia chinensis prevents oxidative stress and protects pancreatic β-cells in streptozotocin induced diabetic rats. J Med Food. 2013;16(8):719-27. doi: 10.1089/jmf.2012.2480, PMID 23957355.
DU S, Liu H, Lei T, Xie X, Wang H, HE X. Mangiferin: an effective therapeutic agent against several disorders. Mol Med Rep. 2018;18(6):4775-86. doi: 10.3892/mmr.2018.9529, PMID 30280187.
Imran M, Arshad MS, Butt MS, Kwon JH, Arshad MU, Sultan MT. Mangiferin: a natural miracle bioactive compound against lifestyle-related disorders. Lipids Health Dis. 2017;16(1):84. doi: 10.1186/s12944-017-0449-y, PMID 28464819.
Asthana RK, Gupta R, Agrawal N, Srivastava A, Chaturvedi U, Kanojiya S. Evaluation of antidyslipidemic effect of mangiferin and amarogentin from swertiachirayita extract in HFD induced charles foster rat model and in vitro antioxidant activity and their docking studies. Int J Pharm Sci Res. 2014;5(9):3733-40.
Rodeiro I, Jose Gomez Lechon M, Perez G, Hernandez I, Herrera JA, Delgado R. Mangifera indica L. extract and mangiferin modulate cytochrome P450 and UDP-glucuronosyltransferase enzymes in primary cultures of human hepatocytes. Phytother Res. 2013;27(5):745-52. doi: 10.1002/ptr.4782, PMID 22815239.
Reddy GD, Reddy AG, Rao GS, Kumar MV. Pharmacokinetic interaction of garlic and atorvastatin in dyslipidemic rats. Indian J Pharmacol. 2012;44(2):246-52. doi: 10.4103/0253-7613.93860, PMID 22529485.
Pan Y, Jagadish P, Tze UY, Ming SL, Hon LK, Siau EE JL. Modulatory effects of mangiferin isolated from aquilaria plants on human cytochrome P450 enzyme (cyp) activities in vitro and in silico studies. NPJ. 2023;13(8). doi: 10.2174/2210315513666230307115348.
Singh RM, Kulkarni AR, Shukla ST, Ganguly K, Chaturvedi K, Kulkarnil VN. Effect of mangiferin on pharmacokinetic antidiabetic and hepatotoxicity of pioglitazone in albino rats. In: tripathi R, sharma V, kumar P, editors. Animal biodiversity and fisheries. New Delhi, India: Discovery Publishing House; 2019. p. 84-105.
Godinez Chaparro B, Quinonez Bastidas GN, Rojas Hernandez IR, Austrich Olivares AM, Mata Bermudez A. Synergistic interaction of a gabapentin- mangiferin combination in formalin-induced secondary mechanical allodynia and hyperalgesia in rats is mediated by activation of no-cyclic GMP-ATP-sensitive K+ channel pathway. Drug Dev Res. 2017;78(8):390-402. doi: 10.1002/ddr.21411, PMID 28940250.
Kirankumar GV, Sekhar HS, Nagaraj K, Nagaraju B, Ravi CM, Nemati H. Drug interaction of repaglinide and mangiferin in rats. Int J Pharm Chem Sci. 2013;2(3):1218-26.
Published
How to Cite
Issue
Section
Copyright (c) 2025 MEESA MADHAVI, YELLU NARSIMHA REDDY
This work is licensed under a Creative Commons Attribution 4.0 International License.
